Study shows the impact of socioeconomic development on global cancer burden

Cancer remains a significant public health challenge, with the GLOBOCAN 2020 report estimating a staggering 19.3 million new cancer cases and 10 million cancer-related deaths globally.

Data Insights – Pharmaceutical Technology

By Company Name No Filter Selected Bristol-Myers Squibb (669) Merck (456) Novartis (367) AstraZeneca (309) F. Hoffmann-La Roche (283) AbbVie (266) Pfizer (254) BeiGene (192)

November 5, 2023

Delabeling penicillin allergy to improve syphilis care

About 10% of Americans believe they are allergic to penicillin, and approximately 90% of those patients are not actually allergic.

October 24, 2024

Biotest AG publishes preliminary business figures – 2024 forecasts partially exceeded – Biotech Investments

Biotest AG / Key word(s): Annual Results Biotest AG publishes preliminary business figures – 2024 forecasts partially exceeded 26-Feb-2025 / 18:22 CET/CEST Disclosure of an

February 27, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.